Skip to Main Content

Paper Details

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma.
J Immunother Cancer
29
2020
  • 1 - 1

Datasets